Three-dimensional bioprinting
Three-dimensional bioprinting has been studied in 10 papers since 2024: none in people yet, 1 in cells, 9 reviews; 9 in the past year. No study of it in people or animals has been published yet. The newest paper, Nov 2, 2026: “3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function”.
10 papers study it1 findingUpdated
2 new papers in 30 daysSee all 10 papers on three-dimensional bioprinting
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
- 1 lab in 1 country
- Cells1
What did studies of three-dimensional bioprinting find?
1Studies of three-dimensional bioprinting measured one outcome, cell viability.
Cell viability
upin reviews1
1 study
Cell viability
upin reviews1
Three-dimensional bioprinting improves cell viability (composite bioinks (alginate and gelatin)) (>= 99%).
“composite bioinks, such as alginate and gelatin, maintained high cell viability greater than or equal to 99%”
Reviewcomposite bioinks (alginate and gelatin)
Transdigital